Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation |
| |
| Authors: | Ratanatharathorn, Voravit Nash, Richard A. Przepiorka, Donna Devine, Steven M. Klein, Jared L. Weisdorf, Daniel Fay, Joseph W. Nademanee, Auayporn Antin, Joseph H. Christiansen, Neal P. van der Jagt, Richard Herzig, Roger H. Litzow, Mark R. Wolff, Steven N. Longo, Walter L. Petersen, Finn B. Karanes, Chatchada Avalos, Belinda Storb, Rainer Buell, Donald N. Maher, Rochelle M. Fitzsimmons, William E. Wingard, John R. |
| |
| Affiliation: | From the University of Michigan, Ann Arbor; Fred Hutchinson CancerResearch Center, Seattle, WA; M.D. Anderson Cancer Center, Houston, TX;Lutheran General Hospital, Chicago, IL; Wayne State University,Detroit, MI; University of Minnesota, Minneapolis; Baylor UniversityMedical Center, Dallas, TX; City of Hope National Medical Center,Duarte, CA; Brigham and Women's Hospital, Boston, MA; Ohio StateUniversity, Columbus, OH; Roswell Park Memorial Institute, Buffalo, NY;Ottawa General Hospital, Ottawa, Ontario, Canada; University ofLouisville, Louisville, KY; Mayo Clinic, Rochester, MN; VanderbiltUniversity Medical Center, Nashville, TN; University of Wisconsin,Madison; University of Utah, Salt Lake City; Fujisawa USA, Deerfield,IL; and University of Florida, Gainesville. |
| |
| Abstract: | |
| |
| Keywords: | |
|
| 点击此处可从《Blood》浏览原始摘要信息 |
|
点击此处可从《Blood》下载全文 |
|
